Business Context and Reporting Period
Company: XpresSpa Group, Inc. (Note: Metadata referenced "XWELL, Inc." but the filing identifies the registrant as XpresSpa Group, Inc.)
Filing Type: Form 8-K (Current Report)
Date: April 17, 2020
Context: The filing reports the amendment and restatement of a material definitive agreement regarding convertible notes issued to Calm.com, Inc. ("Calm").
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or liquidity ratios. The only specific financial figures disclosed relate to the debt instrument:
- Debt Instrument: $2,500,000 aggregate principal amount of 5.00% unsecured convertible Notes due 2022 (the "Calm Notes").
- Warrants: Warrants to purchase 937,500 shares of common stock.
- Warrant Exercise Price: Reduced to $0.175 per share following an anti-dilution trigger.
Material Changes
The primary material change reported is the amendment and restatement of the Calm Note on April 17, 2020. Key modifications include:
- Conversion Limitation: Calm is restricted from converting Series E Convertible Preferred Stock into common stock if such conversion would cause Calm to beneficially own more than 4.99% of the outstanding common stock (the "Beneficial Ownership Limitation").
- Reference to Prior Events: The filing notes a prior securities purchase agreement on March 19, 2020, which triggered the anti-dilution price protection provision reducing the warrant exercise price.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no forward-looking guidance, outlook, or general management commentary regarding future operations or financial performance.
Risks and Contingencies: The filing does not explicitly list new risks or contingencies beyond the structural modification to the debt instrument's conversion rights. The amendment is intended to manage beneficial ownership thresholds.
Investor Verification Checklist
- Verify the exact terms of the "Beneficial Ownership Limitation" in the attached Exhibit 4.1 (Amended and Restated Calm Note).
- Confirm the current outstanding share count to calculate the 4.99% conversion threshold accurately.
- Review the March 19, 2020 securities purchase agreement to understand the full context of the anti-dilution trigger.
- Check subsequent filings for any further amendments to the Calm Notes or warrant exercise prices.